Android app on Google Play

Questcor (QCOR) Sees Upside on Positive Comments on Generic Acthar

August 15, 2012 9:46 AM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Price: $80.07 +2.47%

Rating Summary:
    10 Buy, 6 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 23 | Down: 10 | New: 20
Trade QCOR Now!
Join SI Premium – FREE
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) is seeing upside following positive comments from BofA/ML. The firm said after meetings with Momenta Pharmaceuticals Inc. (Nasdaq: MNTA), management indicated generic Acthar could be commercial infeasible to produce.

Worries about competition for Acthar has been a key overhang on the stock, so the comments are being well received.

Shares of QCOR are up 2.4 percent to $39.90.




You May Also Be Interested In


Related Categories

Analyst Comments, Trader Talk

Related Entities

Bank of America

Add Your Comment